Chicago researchers claimed to develop a new technique to fight type 1 diabetes. The new technique, eliminated the need for drugs that inhibit immune-system activity in diabetic mice that had insulin-producing islet cell transplantation.
Immunosuppressive drugs prevent bodies from rejecting the islet cells, but they’re toxic to the new cells and put patients at risk for infections and cancer, doctors say.
The findings were reported in the journal Proceedings of the National Academy of Science. Miller’s study was funded by the Juvenile Diabetes Research Foundation.
The lead researcher of the study Stephen Miller said,
“we made the recipient feel that the donor cells are their own. This technique is a highly attractive potential therapy for human islet cell transplantation.”